Accordingly, IDO inhibition has shown positive effects in murine models of pancreatic cancer (280) and a study combining IDO inhibitors with DC vaccines for breast cancer patients has completed recruitment (NCT01042535). This evidence concerns the gene IDO1 and pancreatic neoplasm.